IRIS
BRANCACCIO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.949
NA - Nord America 1.940
AS - Asia 1.521
SA - Sud America 424
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 7.871
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.573
US - Stati Uniti d'America 1.897
SG - Singapore 549
IE - Irlanda 501
BR - Brasile 348
CN - Cina 297
GB - Regno Unito 267
VN - Vietnam 233
HK - Hong Kong 230
IT - Italia 133
UA - Ucraina 128
DE - Germania 83
SE - Svezia 57
FR - Francia 56
GR - Grecia 55
KR - Corea 48
BD - Bangladesh 37
AR - Argentina 36
FI - Finlandia 32
IN - India 28
TR - Turchia 25
CA - Canada 17
CZ - Repubblica Ceca 17
JP - Giappone 17
MX - Messico 17
BE - Belgio 14
ID - Indonesia 13
AT - Austria 11
EC - Ecuador 10
IQ - Iraq 9
ZA - Sudafrica 9
PK - Pakistan 8
BO - Bolivia 6
CO - Colombia 5
ET - Etiopia 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
CL - Cile 4
PL - Polonia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EU - Europa 3
KE - Kenya 3
MA - Marocco 3
NI - Nicaragua 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
NL - Olanda 2
NP - Nepal 2
PH - Filippine 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.871
Salva come PNG Salva come JPEG
Città #
Moscow 968
Dublin 501
Singapore 255
Chandler 252
Santa Clara 237
Hong Kong 229
Jacksonville 199
San Jose 135
Ho Chi Minh City 83
Dallas 80
Princeton 72
Medford 69
Ashburn 68
Roxbury 65
Beijing 56
Houston 55
New York 55
Seoul 48
Hanoi 47
The Dalles 44
Munich 34
Caserta 27
Wilmington 27
São Paulo 24
Ann Arbor 22
Des Moines 22
Brno 16
Los Angeles 16
Napoli 15
Brussels 14
Da Nang 14
Nanjing 13
Orem 12
Haiphong 11
Bengaluru 10
Boardman 10
Bremen 10
Milan 10
Porto Alegre 10
Atlanta 9
Belo Horizonte 9
Nuremberg 9
Redwood City 9
Woodbridge 9
Helsinki 8
Memphis 8
Rome 8
San Mateo 8
Shanghai 8
Brasília 7
Campinas 7
Curitiba 7
Mountain View 7
Tokyo 7
Changsha 6
Frankfurt am Main 6
Nanchang 6
Ninh Bình 6
Rio de Janeiro 6
Biên Hòa 5
Cambridge 5
Chennai 5
Guadalajara 5
Guarulhos 5
Hefei 5
Turku 5
Baghdad 4
Bagheria 4
Belford Roxo 4
Caxias do Sul 4
Clifton 4
Columbus 4
Duque de Caxias 4
Franca 4
Ha Long 4
Jakarta 4
Kyiv 4
La Paz 4
Lahore 4
Lima 4
Philadelphia 4
Ribeirão Preto 4
Santo André 4
São Bernardo do Campo 4
Zhengzhou 4
Aversa 3
Bogotá 3
Buffalo 3
Camaçari 3
Can Tho 3
Contagem 3
Denver 3
Fairfield 3
Fortaleza 3
Fuzhou 3
Jinan 3
Johannesburg 3
Joinville 3
London 3
Nairobi 3
Totale 4.141
Salva come PNG Salva come JPEG
Nome #
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 302
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 179
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 166
AISF position paper on HCV in immunocompromised patients 166
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 165
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 156
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 155
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP) 152
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 151
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas 146
[Prevalence and risk factors for bacteriuria in patients with cirrhosis] 144
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 142
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 141
Changing indications for liver transplant: slow decline of hepatitis viruses in Italy 141
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 138
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 138
Virological patterns of HCV patients with failure to interferon-free regimens. 136
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C 135
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 135
[Cutaneous myiasis from Cordylobia anthropophaga in a traveller returning from Senegal: a case study] 134
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 130
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 130
Hepatitis delta infection in Italian patients: towards the end of the story? 126
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir 126
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 125
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 124
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 124
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. 123
. Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience 123
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 118
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 116
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study 114
An a prior prediction model of response to peginterferon plus ribavirin dual therapy in naive patients with genotype 1 chronic hepatitis C 114
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 107
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 104
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 101
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 99
Identification of Naïve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin 98
Interleukin-28B genetic variants in untreated Italian HCV-infected patients : a multicenter study. 97
LONG TERM SAFETY OF ANTI -TNF ALFA IN PATIENTS WITH INFLAMMATORY ARTHRITIS AND HBV INFECTION: FOCUS ON HEPATITIS B SURFACE ANTIBODY STATUS 96
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 95
Recovery of HBV-specific T cell function in patients under long-term effective suppressive therapy by nucleos(t)ide analogues. 93
Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B 92
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. 92
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey 91
Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy 91
Evolving Clinical Landscape of Chronic Hepatitis B:A Multicenter Italian Study 89
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 89
Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study 88
Fever of unknown origin (FUO): Which are the factors influencing the final diagnosis? A 2005-2015 systematic review 88
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV? 87
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir 85
Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs 84
Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population 83
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 82
Influenza vaccination in patients with cirrosi and in liver transplant recipients. 81
Entecavir monotherapy improves renal function in patients developing renal side effects during long-term tenofovir treatment without compromising virological response: a multicenter real-life study in 103 patients 80
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 80
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 80
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 79
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? 78
Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis? 77
Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers 77
The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort 77
Individualized treatment of genotype 1 Naïve patients: An Italian multicenter field practice experience 75
Treatment of chronic hepatitis due to Hepatitis B with Delta virus coinfection 74
Platelets and hepatocellular cancer: Bridging the bench to the clinics 74
Interleukin-28B genetic variants in untreated Italian HCV-infected patients: A multicentre study 70
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 68
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 66
Salvage therapy with follone by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. 66
Hepatitis C Virus Clearance in Older Adults 62
Totale 8.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022510 21 9 12 21 174 8 12 24 25 26 36 142
2022/2023928 79 13 12 78 80 76 2 66 482 6 17 17
2023/2024305 29 8 12 8 115 50 0 7 0 6 14 56
2024/2025984 20 23 8 17 168 116 141 56 155 126 89 65
2025/20264.345 113 162 309 274 364 2.394 195 169 173 84 69 39
Totale 8.010